Search results for "molecular microbiology"
Selected Filters:
Sequence-Specific DNA Assay
Invitrogen™ BenchMark™ Pre-stained Protein Ladder
Thermo Fisher ScientificThe BenchMark Pre-Stained Protein Ladder is a standard used to monitor electrophoresis or electrophoretic transfer from gel to membrane in Western blots.
HypoThermosol® FRS
STEMCELL Technologies Inc.Animal component-free, defined hypothermic (2 - 8°C) preservation medium for a range of cell and tissue types
Nexera Bio - Peace of Mind for Biomolecule Analysis
Discover Shimadzu's new biocompatible UHPLC system designed for analyzing- protein-based pharmaceuticals and antibody drugs
The hidden coagulation risk in plasma-derived biologics
Explore how specialist hemostatic risk testing can prevent costly clinical failures in plasma-derived biologics
New software solutions are rewiring formulation science
From smarter data capture to predictive analysis, next‑generation R&D data platforms are streamlining complexity and accelerating decision‑making across the lab
8 upcoming webinars to expand your research opportunities
Discover the latest tools and techniques to expand your research capacity with expert-led presentations on HTPLC, cell line development, pesticide analysis, and more
Changing the landscape: Disruptive technologies for in vitro diagnostics
The right CMO can provide support to bring disruptive technologies’ potential to fruition
Promising new data on antiviral efficacy of iota-carrageenan against SARS-CoV-2 variants of concern
Data shows that iota-carrageenan might be an effective virus blocker irrespective of present and possible future SARS-CoV-2 mutations
Don't miss out on these 6 new expert webinars
Explore topics from in vitro diagnostics and advances in COVID-19 sample prep to neonatal hypocalcemia and cytotoxicity assay development
Megaruptor® Genomic DNA Shearing for Large Insert Sequencing Library Preparation
Megaruptor® Genomic DNA Shearing for Large Insert Sequencing Library Preparation
Gene editing therapies signal a medical revolution
Casgevy™ and Lyfgenia™ approvals pave the way for personalized gene editing therapies in treating sickle cell disease
High value chemicals for pharmaceuticals could be made cheaper and greener by new catalysts
Making high-value chemicals requires many years and large financial investment
New Collaborative Focus on Targeted Protein Degradation for Cancer Drug Discovery
Eisai enters into collaborative research agreement with University of Dundee


















